Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Published Online: 2007-09-?
Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC
Authors: Alexander M Reznik•Alla S Avedisova•Anatoly B Smulevich•Boris V Andreev•Bryan G Johnson•Darryle D Schoepp•Ferenc Martenyi•Issak Y Gurovich•James A Monn•Kimberley A Jackson•Leonid M Bardenstein•Lu Zhang•Margarita A Morozova•Nikolai G Neznanov•Sandeep T Patil•Sergey N Mosolov•Stephen L Lowe•Vladimir A Tochilov
